Abstract: A computer-implemented method includes establishing a road network model on which a plurality of simulated vehicles may be run. The method also includes setting up a plurality of scenarios under which vehicle driving conditions vary to be run on the road network model. The illustrative method includes receiving energy usage related data for a plurality of simulated vehicles run in at least one of the plurality of scenarios on the road network model. The method further includes calculating a total energy consumption for each of the vehicles. The method additionally includes repeating the receiving and calculating steps to determine how various elements of the road network model and scenarios effect vehicle energy consumption.

Abstract: Compounds are provided for use with glucokinase that comprise the formula: wherein the variables are as defined herein. Also provided are pharmaceutical compositions, kits and articles of manufacture comprising such compounds; methods and intermediates useful for making the compounds; and methods of using said compounds.

Abstract: The present invention is directed to cationic terpolymers, methods to make them, and the use of compositions containing said terpolymers in personal care compositions. The polymers are useful in personal care applications. The cationic terpolymers of this present invention provide the extra conditioning benefits required in a personal care product. These cationic terpolymers also contribute useful conditioning properties to hair-care and skin-care products.

Abstract: This invention relates to hair conditioning formulations comprising at least one aminofunctional polyorganosiloxane. Furthermore, the invention relates to the use of these formulations for the treatment of keratin-containing fibers, preferably human hair.

Abstract: Disclosed are compounds of the following formula: in which R1, R2, R3, R4, R5, R6, R7, X, and t are defined in the specification. Also disclosed are pharmaceutical compositions, kits, and articles of manufacture, which contain the compounds, methods and intermediates useful for making the compounds, and methods of using the compounds to treat diseases, disorders, and conditions related to PARP activity.

Abstract: Compounds of the following formula are provided for use in inhibiting Poly (ADP-ribose) Polymerase (PARP): wherein the variables are defined herein. Also provided are pharmaceutical compositions, kits and articles of manufacture comprising such compounds, methods and intermediates useful for making the compounds, and methods of using the compounds.

Abstract: Disclosed are compounds of the following formula: in which R1, R2, R5, R6, R7, R11, X, and m are defined in the specification. Also disclosed are pharmaceutical compositions, kits, and articles of manufacture, which contain the compounds, methods and intermediates useful for making the compounds, and methods of using the compounds to treat diseases, disorders, and conditions related to PARP activity.

Abstract: Polymeric anti-microbial agents produced by substituting the nitrogen atoms in the backbone of ethylenimine polymers, for example, substitution with aralkyl groups, are provided. The agents are believed to have low human toxicity while being effective against a variety of pathogens and are useful in applications involving human contact, such as cosmetics, hair care products and textiles, as well as in applications with much less human contact, such as coatings.

Abstract: Disclosed are compounds of the following formula: in which R1, R2, R3, R4, R5, R6, R7, X, and t are defined in the specification. Also disclosed are pharmaceutical compositions, kits, and articles of manufacture, which contain the compounds, methods and intermediates useful for making the compounds, and methods of using the compounds to treat diseases, disorders, and conditions related to PARP activity.

Abstract: Disclosed are compounds of the following formula: in which R1, R2, R5, R6, R7, R31, u, and X are defined in the specification. Also disclosed are pharmaceutical compositions, kits, and articles of manufacture, which contain the compounds, methods and intermediates useful for making the compounds, and methods of using the compounds to treat diseases, disorders, and conditions related to PARP activity.

Abstract: A method for controlling a vehicle including a fuel cell system and an energy storage unit includes, if the fuel cell system is charging the energy storage unit, determining an average ratio of (i) a change in energy stored in the energy storage unit and (ii) a mass of hydrogen consumed by the fuel cell system to generate the change in energy stored in the energy storage unit. The method also includes, if the fuel cell system is not charging the energy storage unit, selecting a target operating power for the fuel cell system based on vehicle power demand and the determined ratio that sufficiently minimizes drive cycle hydrogen consumption by the fuel cell system.

Abstract: Water-soluble functionalized cationic copolymers obtainable by a process which comprises reacting a cationic base polymer which contains amino groups with at least one functional compound reactive to at least a part of the amino groups on the base polymer, are useful in personal care and cosmetic formulations.

Abstract: Disclosed are compounds of the following formula: in which R1, R2, R3, R4, R5, R6, R7, X, and t are defined in the specification. Also disclosed are pharmaceutical compositions, kits, and articles of manufacture, which contain the compounds, methods and intermediates useful for making the compounds, and methods of using the compounds to treat diseases, disorders, and conditions related to PARP activity.

Abstract: A propulsion system includes a first torque producing arrangement including an electric machine configured to a first energy source supplying electrical energy to the electric machine. The system also includes a second torque producing arrangement having an engine connected to a second energy source configured to supply gaseous fuel to the engine. The system has a hydrogen production system having an electrolyzer, a water source, a hydrogen dispensing and loading system, and a connection to an electricity grid. Hydrogen is loaded to the second energy source when the electrolyzer is electrolyzing the water. The engine further connects to a third energy source configured to supply a non-hydrogen fuel to the engine. The system has a controller electrically connected to the motor and the engine capable of selecting the propulsion component and the fuel source.

Abstract: Polymeric anti-microbial agents produced by substituting the nitrogen atoms in the backbone of ethylenimine polymers, for example, substitution with aralkyl groups, are provided. The agents are believed to have low human toxicity while being effective against a variety of pathogens and are useful in applications involving human contact, such as cosmetics, hair care products and textiles, as well as in applications with much less human contact, such as coatings.

Abstract: The invention relates to inhibitors of enzymes that disrupt the assembly and function of the mitotic spindle, compositions comprising the inhibitors of Formula (I), kits and articles of manufacture comprising the inhibitors and inhibitor compositions, and methods of using the inhibitors and inhibitor compositions. The inhibitors and inhibitor compositions are useful for treating, preventing or modulating diseases in which mitotic kinesins, including kinesin-like spindle protein (KSP), may be involved; symptoms of such diseases; or the effect of other physiological events mediated by mitotic kinesins, including KSP.

Abstract: Compounds are provided for use with glucokinase that comprise the formula: wherein the variables are as defined herein. Also provided are pharmaceutical compositions, kits and articles of manufacture comprising such compounds; methods and intermediates useful for making the compounds; and methods of using said compounds.

Abstract: The present invention is directed to cationic nanoparticles, methods to make them, and the use of compositions containing said nanoparticles in personal care compositions or formulations. The nanoparticles are useful in personal care applications and impart antimicrobial properties to home and personal care products containing them. These cationic nanoparticles also contribute useful conditioning properties to hair-care and skin-care products.

Abstract: The present invention is directed to cationic terpolymers, methods to make them, and the use of compositions containing said terpolymers in personal care compositions. The polymers are useful in personal care applications. The cationic terpolymers of this present invention provide the extra conditioning benefits required in a personal care product. These cationic terpolymers also contribute useful conditioning properties to hair-care and skin-care products.

Abstract: A propulsion system includes a first torque producing arrangement including an electric machine configured to a first energy source supplying electrical energy to the electric machine. The system also includes a second torque producing arrangement having an engine connected to a second energy source configured to supply gaseous fuel to the engine. The system has a hydrogen production system having an electrolyzer, a water source, a hydrogen dispensing and loading system, and a connection to an electricity grid. Hydrogen is loaded to the second energy source when the electrolyzer is electrolyzing the water. The engine further connects to a third energy source configured to supply a non-hydrogen fuel to the engine. The system has a controller electrically connected to the motor and the engine capable of selecting the propulsion component and the fuel source.